News

By using stem cell therapy, scientists and clinicians aim not only to slow disease progression—but to restore lost functions and improve quality of life. In MS, for example, ...
Source Reference: Good SD, et al "A new toxicity syndrome in patients with autoimmune disease treated with CAR T-cell therapy" Lancet Rheumatol 2025; DOI: 10.1016/S2665-9913(25)00100-6.
STAT Plus: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results By Elizabeth Cooney. Health. Health June 20, 2025.
VX-264 and zimislecel came from Vertex’s 2019 acquisition of privately held Semma Therapeutics. The $950 million deal established Vertex’s presence in type 1 diabetes therapy R&D. In 2022 ...
New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living with the condition. Skip to Article Set weather ...
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
About 100,000 people in the United States have sickle cell disease. For the 20,000 or so with the most severe disease, gene therapy may be their only hope of living a normal life.
Doctors and specialists at the Murdoch Children's Research Institute in Melbourne, Australia, are studying and reprogramming the potential of the blood to treat heart failure in children.
Pressure to make cell and gene therapies more affordable will force the industry to overcome its reticence and embrace closed production systems, automation, and artificial intelligence (AI). So ...
Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since raising $401 million nearly two years ago.
Promising cell therapy offers hope for relapsed or refractory T-cell leukaemia. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 10 / 241007115451.htm ...
Diabetes took over her life, until a stem cell therapy freed her. Scientists are making progress replacing the critical insulin-producing cells that are destroyed by the disease.